Atlas Trials

Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015

Clinical trial NCT02320656 · COMPLETED

Trial details

NCT number
NCT02320656
Sponsor
Institut Paoli-Calmettes
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute LeukemiaMyelodysplastic SyndromesMyeloproliferative Disorders
Start date
2014-05-01
Primary completion
2024-10-30
Enrollment
650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.